The impact of body mass index on the one year outcomes of patients treated by percutaneous coronary intervention with Biolimus- and Sirolimus-eluting stents (from the LEADERS Trial).
about
Impact of Modifiable Cardiovascular Risk Factors on Mortality After Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of 100 StudiesThirty-year (1975 to 2005) trends in the incidence rates, clinical features, treatment practices, and short-term outcomes of patients <55 years of age hospitalized with an initial acute myocardial infarction.Impact of body mass index on in-hospital complications in patients undergoing percutaneous coronary intervention in a Japanese real-world multicenter registry.Relationship between Body Mass Index and Outcome of Elective Percutaneous Coronary Intervention.Neck circumference and central obesity are independent predictors of coronary artery disease in patients undergoing coronary angiography.Adipokines and thrombosis.Biology of metabolic syndrome in a vascular patient.Identifying determinants of variability to tailor aspirin therapy.Obesity and cardiovascular outcomes: a review.Clinical pharmacokinetics and pharmacodynamics of clopidogrel.Obesity and Cardiovascular Disease: a Risk Factor or a Risk Marker?Obesity and intracranial in-stent thrombosis.Obesity does not increase complication rate of percutaneous epicardial access.
P2860
Q26774723-958CB8A2-A542-40C4-BCFD-F5019B21118EQ35146193-EAC35679-F2C6-48AB-8BB9-CEE7032C16A5Q35416397-73806416-8AD8-4564-84A3-8B8A9463C72CQ35827425-527FD32F-71B1-4515-BCA0-00A86F6B32F0Q36404555-FC2A3D95-9AA5-47B4-A594-3E48BC1021FFQ37919150-566F9299-8CD5-4E04-AEC8-4AB18DC51E74Q38018900-91233A9D-52F3-45CF-9089-36CFFE826041Q38087384-21C2FA4F-3C16-4DBF-82B0-4CEAE3F199F2Q38187956-FF716237-81EC-441E-97C1-9282F382EBCDQ38307535-D10FAB0B-D299-42EA-94C3-F64205A26AD4Q38773385-6DDEBE00-888C-48FD-BC91-F1129A4DDDF0Q43611937-002D34CD-9CAE-43FC-8072-824A50ECBD22Q50108911-2E640CDE-45EF-41BA-BBDC-83BAFAFE3073
P2860
The impact of body mass index on the one year outcomes of patients treated by percutaneous coronary intervention with Biolimus- and Sirolimus-eluting stents (from the LEADERS Trial).
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
The impact of body mass index ...... ents (from the LEADERS Trial).
@en
The impact of body mass index ...... - and Sirolimus-eluting stents
@nl
type
label
The impact of body mass index ...... ents (from the LEADERS Trial).
@en
The impact of body mass index ...... - and Sirolimus-eluting stents
@nl
prefLabel
The impact of body mass index ...... ents (from the LEADERS Trial).
@en
The impact of body mass index ...... - and Sirolimus-eluting stents
@nl
P2093
P50
P1476
The impact of body mass index ...... ents (from the LEADERS Trial).
@en
P2093
Axel Linke
Bernhard Meier
Dick Goedhart
Franz Eberli
Gerrit-Anne van Es
Giovanna Sarno
Hector M Garcia-Garcia
Patrick Serruys
Pedro Eerdmans
Robert Jan van Geuns
P304
P356
10.1016/J.AMJCARD.2009.09.055
P407
P577
2010-01-05T00:00:00Z